AVRO
Income statement / Annual
Last year (2024), AVROBIO, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, AVROBIO, Inc.'s net income was -$57.98 M.
See AVROBIO, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$617.00 K
|
$4.17 M
|
$1.40 M
|
$1.21 M
|
$850.00 K
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
-$617.00 K
|
-$4.17 M
|
-$1.40 M
|
-$1.21 M
|
-$850.00 K
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Research and Development Expenses |
$41.36 M
|
$47.08 M
|
$72.19 M
|
$83.11 M
|
$87.24 M
|
$54.97 M
|
$35.10 M
|
$15.19 M
|
$2.66 M
|
General & Administrative Expenses |
$16.65 M
|
$22.69 M
|
$33.25 M
|
$35.73 M
|
$32.99 M
|
$20.84 M
|
$11.15 M
|
$3.20 M
|
$1.96 M
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$16.65 M
|
$23.97 M
|
$33.25 M
|
$35.73 M
|
$32.99 M
|
$20.84 M
|
$11.15 M
|
$3.20 M
|
$1.96 M
|
Other Expenses |
$0.00
|
$0.00
|
-$456.00 K
|
-$285.00 K
|
$516.00 K
|
$2.84 M
|
-$118.00 K
|
-$19.00 K
|
-$6.00 K
|
Operating Expenses |
$58.02 M
|
$71.05 M
|
$105.43 M
|
$118.84 M
|
$120.23 M
|
$75.81 M
|
$46.24 M
|
$18.39 M
|
$4.63 M
|
Cost And Expenses |
$0.00
|
$71.67 M
|
$105.43 M
|
$118.84 M
|
$120.23 M
|
$75.81 M
|
$46.24 M
|
$18.39 M
|
$4.63 M
|
Interest Income |
$4.26 M
|
$2.42 M
|
$299.00
|
$0.00
|
$719.00 K
|
$2.93 M
|
$1.73 M
|
$57.00 K
|
$6.00 K
|
Interest Expense |
-$107.00 K
|
$2.42 M
|
$299.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$0.00
|
$617.00 K
|
$1.44 M
|
$1.40 M
|
$1.21 M
|
$850.00 K
|
$380.00 K
|
$45.00 K
|
$39.00 K
|
EBITDA |
-$58.02 M |
-$71.05 M |
-$105.43 M |
-$118.84 M |
-$120.23 M |
-$75.81 M |
-$46.24 M |
-$18.04 M |
-$4.59 M |
EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$33.00 K
|
$84.20 M
|
-$456.00 K
|
-$285.00 K
|
$516.00 K
|
$2.84 M
|
-$118.00 K
|
-$262.00 K
|
-$39.00 K
|
Income Before Tax |
-$57.98 M
|
$12.53 M
|
-$105.89 M
|
-$119.13 M
|
-$119.71 M
|
-$72.97 M
|
-$46.36 M
|
-$18.65 M
|
-$4.66 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$377.00 K
|
$157.00 K
|
-$1.40 M
|
-$1.21 M
|
-$850.00 K
|
-$118.00 K
|
$243.00 K
|
-$6.00 K
|
Net Income |
-$57.98 M
|
$12.16 M
|
-$106.05 M
|
-$117.73 M
|
-$118.51 M
|
-$72.12 M
|
-$46.36 M
|
-$18.65 M
|
-$4.66 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
EPS |
-6.83 |
0.27 |
-2.42 |
-2.75 |
-3.27 |
-2.63 |
-3.45 |
-1.15 |
-0.67 |
EPS Diluted |
-6.83 |
0.27 |
-2.42 |
-2.75 |
-3.27 |
-2.63 |
-3.45 |
-1.15 |
-0.67 |
Weighted Average Shares Out |
$8.49 M
|
$4.50 M
|
$4.37 M
|
$4.29 M
|
$3.62 M
|
$2.74 M
|
$1.34 M
|
$1.62 M
|
$692.22 K
|
Weighted Average Shares Out Diluted |
$8.49 M
|
$4.46 M
|
$4.37 M
|
$4.29 M
|
$3.62 M
|
$2.74 M
|
$1.34 M
|
$1.62 M
|
$692.22 K
|
Link |
|
|
|
|
|
|
|
|
|